Understanding Pharma: A Primer on how Pharmaceutical Companies Really Work |
From inside the book
Results 1-3 of 16
Page 151
... detailing - telephone calls rather than in - person visits . 2. To pursue that approach , we'll need as many reps as our ... detail " — a carefully structured face - to - face interchange with target prescribers ( first and foremost ...
... detailing - telephone calls rather than in - person visits . 2. To pursue that approach , we'll need as many reps as our ... detail " — a carefully structured face - to - face interchange with target prescribers ( first and foremost ...
Page 156
... detailing physicians in that profile . ( See Figure 8.6 ) Figure 8.6 Selecting Target Segments : A Balancing Act Decile 10 Decile 7 Revenue Prescription volume in target therapeutic area Decile 7 Cost Decile 7 Decile 1 Source : Campbell ...
... detailing physicians in that profile . ( See Figure 8.6 ) Figure 8.6 Selecting Target Segments : A Balancing Act Decile 10 Decile 7 Revenue Prescription volume in target therapeutic area Decile 7 Cost Decile 7 Decile 1 Source : Campbell ...
Page 165
... detail the same products . They may have different promotional priorities among those products or present different ... detailing . Less frequently , pharmaceutical companies make major sizing changes such as adding a new sales force or ...
... detail the same products . They may have different promotional priorities among those products or present different ... detailing . Less frequently , pharmaceutical companies make major sizing changes such as adding a new sales force or ...
Contents
Introduction to the Industry | 1 |
How Are Drugs Classified? | 23 |
How Do Drugs Enter the US Market? | 30 |
Copyright | |
13 other sections not shown
Common terms and phrases
administration adverse event batch record brand Business Development Campbell Alliance clinical development clinical trials commercial company's compliance compounds contract Corporate costs customer segments deal detail discounts Discovery disease dispense distribution Drug Development drug product effective ensure Evaluation FDA approval Figure formulary formulation function global healthcare HER2 Herceptin hospital identify incentive key opinion leaders launch Lipitor managed care Managed Markets Manufacturing Operations manufacturing process market share monitor Operational Model organizations outsource overall packaging patients payers PBMs performance Pfizer pharma companies pharmaceutical companies pharmaceutical industry pharmacists pharmacy benefit Pharmacy Benefit Managers Phase physicians potential preclinical prescribers pricing professional programs promotional purchasing rebates regimen Regulatory Affairs responsible retail pharmacies role sales force sales representatives Source specific strategy Supply Chain Management target testing therapeutic area therapy tion treatment typically Warner-Lambert